Cisplatin nephrotoxicity (Q78761584)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13680535%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

review article

1 reference

title

Cisplatin nephrotoxicity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13680535%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

1 reference

Istvan Arany

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13680535%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

Robert L Safirstein

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13680535%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

publication date

1 September 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13680535%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

published in

Seminars in Nephrology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13680535%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13680535%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13680535%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

page(s)

460-464

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13680535%20AND%20SRC:MED&resulttype=core&format=json

cis-Dichlorodiammineplatinum(II) (NSC-119 875): preclinical toxicologic evaluation of intravenous injection in dogs, monkeys and mice

16 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0270-9295%2803%2900089-5

7 January 2021

The renal pathology in clinical trials of cis-platinum (II) diamminedichloride

1 reference

https://api.crossref.org/works/10.1016%2FS0270-9295%2803%2900089-5

7 January 2021

Uptake and metabolism of cisplatin by rat kidney

1 reference

https://api.crossref.org/works/10.1016%2FS0270-9295%2803%2900089-5

7 January 2021

Cisplatin nephrotoxicity: insights into mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0270-9295%2803%2900089-5

7 January 2021

Induction of p21WAF1/CIP1/SDI1 in kidney tubule cells affects the course of cisplatin-induced acute renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0270-9295%2803%2900089-5

7 January 2021

Mutagenic activity and identification of excreted platinum in human and rat urine and rat plasma after administration of cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FS0270-9295%2803%2900089-5

7 January 2021

Inhibition of gamma-glutamyl transpeptidase or cysteine S-conjugate beta-lyase activity blocks the nephrotoxicity of cisplatin in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0270-9295%2803%2900089-5

7 January 2021

Immunochemical quantitation of adducts induced in DNA by cis-diamminedichloroplatinum (II) and analysis of adduct-related DNA-unwinding

1 reference

https://api.crossref.org/works/10.1016%2FS0270-9295%2803%2900089-5

7 January 2021

The stress-activated protein kinase pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0270-9295%2803%2900089-5

7 January 2021

The c-Jun N-terminal protein kinase family of mitogen-activated protein kinases (JNK MAPKs).

1 reference

https://api.crossref.org/works/10.1016%2FS0270-9295%2803%2900089-5

7 January 2021

The JNK signal transduction pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0270-9295%2803%2900089-5

7 January 2021

The stress-activated protein kinase pathway mediates cell death following injury induced by cis-platinum, UV irradiation or heat

1 reference

https://api.crossref.org/works/10.1016%2FS0270-9295%2803%2900089-5

7 January 2021

Lack of c-Jun activity increases survival to cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FS0270-9295%2803%2900089-5

7 January 2021

Role and regulation of activation of caspases in cisplatin-induced injury to renal tubular epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0270-9295%2803%2900089-5

7 January 2021

Cisplatin-induced renal cell apoptosis: caspase 3-dependent and -independent pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0270-9295%2803%2900089-5

7 January 2021

Translocation of SAPK/JNK to mitochondria and interaction with Bcl-x(L) in response to DNA damage

1 reference

https://api.crossref.org/works/10.1016%2FS0270-9295%2803%2900089-5

7 January 2021

Protein kinase C-alpha and ERK1/2 mediate mitochondrial dysfunction, decreases in active Na+ transport, and cisplatin-induced apoptosis in renal cells

1 reference

https://api.crossref.org/works/10.1016%2FS0270-9295%2803%2900089-5

7 January 2021

TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0270-9295%2803%2900089-5

7 January 2021

Antibody to intercellular adhesion molecule 1 protects the kidney against ischemic injury

1 reference

https://api.crossref.org/works/10.1016%2FS0270-9295%2803%2900089-5

7 January 2021

Direct evidence for tumor necrosis factor-induced mitochondrial reactive oxygen intermediates and their involvement in cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0270-9295%2803%2900089-5

7 January 2021

Cisplatin nephrotoxicity. A review

1 reference

https://api.crossref.org/works/10.1016%2FS0270-9295%2803%2900089-5

7 January 2021

Hypomagnesemia and Renal Magnesium Wasting in Patients Receiving Cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FS0270-9295%2803%2900089-5

7 January 2021

Hypomagnesemia, renal dysfunction, and Raynaud's phenomenon in patients treated with cisplatin, vinblastine, and bleomycin

1 reference

https://api.crossref.org/works/10.1016%2FS0270-9295%2803%2900089-5

7 January 2021

Studies on the pathogenesis of cisplatin-induced hypomagnesemia in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0270-9295%2803%2900089-5

7 January 2021

Renal function related to different treatment modalities for malignant germ cell tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0270-9295%2803%2900089-5

7 January 2021

Modification of cisplatin toxicity with diethyldithiocarbamate

1 reference

https://api.crossref.org/works/10.1016%2FS0270-9295%2803%2900089-5

7 January 2021

The use of reduced doses of amifostine to ameliorate nephrotoxicity of cisplatin/ifosfamide-based chemotherapy in patients with solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0270-9295%2803%2900089-5

7 January 2021

Pharmacologic approaches to protection against radiation-induced lethality and other damage

1 reference

https://api.crossref.org/works/10.1016%2FS0270-9295%2803%2900089-5

7 January 2021

Inhibition of extracellular signal-regulated protein kinase or c-Jun N-terminal protein kinase cascade, differentially activated by cisplatin, sensitizes human ovarian cancer cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0270-9295%2803%2900089-5

7 January 2021

Requirement for ERK activation in cisplatin-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0270-9295%2803%2900089-5

7 January 2021

10.1016/S0270-9295(03)00089-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:13680535%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

1 reference